A phase II study of intrapleural immunochemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy, and long-term subcutaneous IL-2 in stage II-III malignant pleural mesothelioma.
Editorial Article
Overview
publication date
- January 30, 2007
published in
Research
keywords
- Mesothelioma
- Pleural Neoplasms
Identity
Scopus Document Identifier
- 33847304106
PubMed ID
- 17267238
Additional Document Info
has global citation frequency
volume
- 31
issue
- 3